Glaucoma Clinical Trial
Official title:
Neurovascular Coupling in Patients With Open Angle Glaucoma
Verified date | November 2014 |
Source | Medical University of Vienna |
Contact | n/a |
Is FDA regulated | No |
Health authority | Austria: Agency for Health and Food Safety |
Study type | Observational |
A variety of studies demonstrate that ocular blood flow is altered in glaucoma. Various
animal and human studies have shown an increase in retinal and optic nerve head blood flow
in response to diffuse luminance flicker. Based on studies with ERG, this effect has been
attributed to augmented activity in the retinal ganglion cells and associated axons
indicating a coupling mechanism between neuronal activity and retinal blood flow. Whereas a
variety of studies have confirmed these effects, the knowledge about this coupling in the
retina of patients with glaucoma is sparse.
Recently the investigators could show that flicker induced vasodilatation is blunted in
patients with open angle glaucoma. However, the investigators results are limited by the
fact that only data about retinal vessel diameters, not blood flow per se, are available.
The further development of the investigators current flicker stimulation technique now
allows us to determine blood flow velocity during flicker stimulation. Thus, in the current
study, the investigators set out to determine whether this blood flow response is impaired
in patients with glaucoma as compared to those in healthy volunteers and whether this is
related to altered neural activity.
The study objective was, to investigate whether the blood flow response to flicker
stimulation is altered in patients with glaucoma.
Status | Terminated |
Enrollment | 15 |
Est. completion date | May 2012 |
Est. primary completion date | April 2007 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Men and women aged between 20 and 80 years. - Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant. - Inclusion criteria of patients are open angle glaucoma. - Men and women will be included in equal parts. A pregnancy test will be performed at screening. - Ametropia of less than 3 diopters and anisometropia of less than 1 diopter. Exclusion Criteria: - Treatment with vasoactive drugs. - Presence of intraocular pathology other than open angle glaucoma. - Presence of ocular hypertension or PEX (pseudoexfoliation) glaucoma - History or family history of epilepsy. - Pregnancy. - Diabetes mellitus. |
N/A
Country | Name | City | State |
---|---|---|---|
Austria | Department of Clinical Pharmacology, Meical University of Vienna, Austria | Vienna |
Lead Sponsor | Collaborator |
---|---|
Medical University of Vienna |
Austria,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Retinal blood velocity (laser Doppler velocimetry) | measurements done only once on the studyday | No | |
Primary | Retinal arterial and venous diameter (Retinal vessel analyzer) | measurements done only once on the studyday | No | |
Primary | Optic nerve head blood flow (laser Doppler flowmetry) | measurements done only once on the studyday | No | |
Primary | Latency and amplitude (pattern ERG) | measurements done only once on the studyday | No | |
Secondary | Mean arterial pressure | measurements done only once on the studyday | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06000865 -
Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE
|
N/A | |
Recruiting |
NCT06278597 -
Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03274024 -
The Asia Primary Tube Versus Trab (TVT) Study
|
N/A | |
Completed |
NCT04552964 -
Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma
|
N/A | |
Recruiting |
NCT01957267 -
Functional and Structural Imaging for Glaucoma
|
||
Active, not recruiting |
NCT04624698 -
iStent Inject New Enrollment Post-Approval Study
|
N/A | |
Completed |
NCT04020705 -
The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma
|
N/A | |
Completed |
NCT03150160 -
Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma
|
Phase 4 | |
Not yet recruiting |
NCT05581498 -
Glaucoma Exercise as Medicine Study (GEMS).
|
N/A | |
Recruiting |
NCT02921568 -
Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes
|
N/A | |
Active, not recruiting |
NCT02901730 -
Clinical Study of LPI With Different Laser Wavelengths
|
N/A | |
Completed |
NCT02955849 -
A Trial of China Laser and Surgery Study Glaucoma in Rural China
|
Early Phase 1 | |
Recruiting |
NCT02554214 -
Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device
|
N/A | |
Recruiting |
NCT02471105 -
Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml
|
Phase 4 | |
Active, not recruiting |
NCT02390284 -
Stop Retinal Ganglion Cell Dysfunction Study
|
Phase 3 | |
Completed |
NCT02628223 -
180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma
|
N/A | |
Completed |
NCT02653963 -
Triamcinolone for Ahmed Glaucoma Valve
|
N/A | |
Completed |
NCT02390245 -
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
|
N/A | |
Completed |
NCT02246764 -
Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
|
Phase 3 |